Health Organisation, Policy and Economics (HOPE) group, School of Health Sciences, University of Manchester, Manchester, UK
Division of Nursing, Midwifery & Social Work, School of Health Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
BMJ Open. 2022 Jan 6;12(1):e056790. doi: 10.1136/bmjopen-2021-056790.
To estimate and examine the direct healthcare costs of treating people with open venous leg ulcers in the UK.
Cost-of-illness study.
A cross-sectional survey of nine National Health Service community locales over 2-week periods in 2015/2016.
We examined the resource use and prevalence of venous leg ulcer treatment in the community. Examination of variation in these obtained costs was performed by ordinary least squares regression. We used additional resource use information from a randomised control trial and extrapolated costs to the UK for an annual period.
The average 2-week per person cost of treating patients where a venous leg ulceration was the primary (most severe) wound was estimated at £166.39 (95% CI £157.78 to £175.00) with community staff time making up over half of this amount. Costs were higher where antimicrobial dressings were used and where wound care was delivered in the home. Among those with any recorded venous leg ulcer (primary and non-primary), we derived a point prevalence of 3.2 per 10 000 population and estimated that the annual prevalence could be no greater than 82.4 per 10 000 population. We estimated that the national cost of treating a venous leg ulcer was £102 million with a per person annual cost at £4787.70.
Our point prevalence figures are in line with the literature. However, our annual prevalence estimations and costs are far lower than those reported in recent literature which suggests that the costs of treating venous leg ulcers are lower than previously thought. Movement towards routinely collected and useable community care activity would help provide a transparent and deeper understanding of the scale and cost of wound care in the UK.
评估并考察在英国治疗开放性静脉溃疡患者的直接医疗成本。
疾病成本研究。
2015/2016 年,在九个国民保健署社区进行为期两周的横断面调查。
我们检查了社区中静脉性腿部溃疡治疗的资源利用情况和患病率。通过普通最小二乘法回归分析了这些获得的成本的变化。我们使用了一项随机对照试验的额外资源利用信息,并将成本外推到英国的年度期间。
每两周治疗一次静脉性腿部溃疡患者(最严重的伤口)的人均成本估计为 166.39 英镑(95%CI 157.78 至 175.00),其中社区工作人员的时间占了一半以上。在使用抗菌敷料和家庭伤口护理的情况下,成本更高。在有任何记录的静脉性腿部溃疡(原发性和非原发性)的患者中,我们得出的点患病率为每 10000 人口 3.2 例,估计每年的患病率不超过每 10000 人口 82.4 例。我们估计,治疗静脉性腿部溃疡的全国费用为 1.02 亿英镑,人均年费用为 4787.70 英镑。
我们的点患病率数据与文献相符。然而,我们的年度患病率估计和成本远低于最近文献中报告的数字,这表明治疗静脉性腿部溃疡的成本低于先前的估计。常规收集和使用社区护理活动的工作将有助于提供英国伤口护理的规模和成本的透明和更深入的了解。